Humacyte Inc. (HUMA)

HUMA trades at $2.46, 64.0% above the near-term max pain of $1.5 expiring Oct 17, 2025 (11 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($1-$2), reflecting growing call interest at higher strikes. Key magnetic zone at 2 where 6 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for HUMA shows an upward trend from 1 to 2, suggesting bullish positioning in longer-dated options. The 67% spread signals divergent expectations across timeframes. Most levels below 2.46 may cap rallies. Strong magnetic level at 2 (6 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.